Frenova Empowers Investigators and Research Teams
Why Frenova? As a Fresenius Medical Care company, Frenova manages the world’s largest network of renal research assets: over 550…
Building a Global Research Network: Chronic Kidney Disease as a Public Health Crisis
At least 20% of people aged 65 to 74, and 50% of people over 75, have chronic kidney disease. However,…
Missed Revenue in Clinical Research: 1 Study, 10 Sites, $154,000 Caught
Whether from faulty sponsor payment systems, incomplete invoicing, or other causes, private practice investigational sites routinely miss out on significant…
Start with the Patient in Mind – Interview With Patient Partner Donnie King
Start with the patient in mind — let’s renew our resolve to represent those who participate in studies to advance…
Frenova Helps With Business, Allows Principal Investigator to Focus on Care
Clinical investigators regularly report that logistical barriers hinder their conduct of clinical trials. Physician and staff workload balance, the time…
Research as Care
Speed is key in bringing new drugs to patients. Speed in clearing regulatory hurdles, gearing up to product launch, gaining…
F1RST Up®: Accelerating Clinical Trial Start-Up
Despite the pressing need to bring novel therapies to patients with renal impairments, the development time and cost to bring…
Including All Stakeholders in the Clinical Ecosystem
The success of clinical research relies not only on patient centricity, but also on collaboration between all stakeholders within the…
Education Key to Transforming Physicians into Clinical Trial Advocates
Although one path to alleviating the chronic shortage of principal investigators is to recruit them from among the ranks of…
Market Research in the Age of AI and Big Data
In a competitive and global business environment, pharmaceutical companies are starting to become wiser when it comes to using market…